Registered entities
IMPEL PHARMACEUTICALS INC
Reg. No. 1445499United States
Innovation
12 patent families (10 granted) — focus: Human necessities; filing pace slowing. Cited 2,853 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 10 |
| 2023 | 9 |
| 2024 | 4 |
Social engagement
Social engagement: 9.9K social following, 4 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include KKR, Norwest; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 2 | 33% |
| Other / undisclosed | 1 | 17% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
27 Aug 2025 · leadership_hire
Based on job postings tracked across public sources.